23.12.2014 08:30:25
|
DSM to sell Euroresins to Cathay Investments
Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has reached agreement with Cathay Investments for the sale of Euroresins. Subject to customary approvals and notifications, the transaction is expected to close in Q1 2015. Financial details will not be disclosed at this time.
Euroresins is a distributor of products to the composite resins industry with activities in nine countries in Europe, including the United Kingdom, Italy and France. Euroresins realizes sales of approximately €90 million with around 70 employees. All employees will on the closing date transfer to the new owner.
The sale of Euroresins is in line with the strategic actions DSM is pursuing for Composite Resins, as announced in November 2014.
Cathay Investments is the UK holding company for a group of companies engaged in chemical distribution and trading. Cathay's principal trading business is Cathay Composites, which distributes glass fiber, resins and other composite materials throughout the UK and Scandinavia. Since its establishment Cathay has grown its portfolio to six companies.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications Herman Betten tel.+31(0)455782017 email media.contacts@dsm.com | DSM Investor Relations Dave Huizing tel. +31(0)455782864 email investor.relations@dsm.com |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DSM NVmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DSM NVmehr Analysen
Aktien in diesem Artikel
DSM NV | 108,95 | -0,86% |